Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection
- PMID: 20015984
- PMCID: PMC2820937
- DOI: 10.1128/JVI.01863-09
Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection
Abstract
Human immunodeficiency virus type 1 (HIV-1)-associated dementia (HAD) is a severe neurological disease that affects a subset of HIV-1-infected individuals. Increased compartmentalization has been reported between blood and cerebrospinal fluid (CSF) HIV-1 populations in subjects with HAD, but it is still not known when compartmentalization arises during the course of infection. To assess HIV-1 genetic compartmentalization early during infection, we compared HIV-1 populations in the peripheral blood and CSF in 11 primary infection subjects, with analysis of longitudinal samples over the first 18 months for a subset of subjects. We used heteroduplex tracking assays targeting the variable regions of env and single-genome amplification and sequence analysis of the full-length env gene to identify CSF-compartmentalized variants and to examine viral genotypes within the compartmentalized populations. For most subjects, HIV-1 populations were equilibrated between the blood and CSF compartments. However, compartmentalized HIV-1 populations were detected in the CSF of three primary infection subjects, and longitudinal analysis of one subject revealed that compartmentalization during primary HIV-1 infection was resolved. Clonal amplification of specific HIV-1 variants was identified in the CSF population of one primary infection subject. Our data show that compartmentalization can occur in the central nervous system (CNS) of subjects in primary HIV-1 infection in part through persistence of the putative transmitted parental variant or via viral genetic adaptation to the CNS environment. The presence of distinct HIV-1 populations in the CSF indicates that independent HIV-1 replication can occur in the CNS, even early after HIV-1 transmission.
Figures
References
-
- Blennow, K., P. Fredman, A. Wallin, C. G. Gottfries, I. Karlsson, G. Langstrom, I. Skoog, L. Svennerholm, and C. Wikkelso. 1993. Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. Eur. Neurol. 33:129-133. - PubMed
-
- Boisse, L., M. J. Gill, and C. Power. 2008. HIV infection of the central nervous system: clinical features and neuropathogenesis. Neurol. Clin. 26:799-819. - PubMed
-
- Brew, B. J., R. B. Bhalla, M. Paul, H. Gallardo, J. C. McArthur, M. K. Schwartz, and R. W. Price. 1990. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. Ann. Neurol. 28:556-560. - PubMed
-
- Cinque, P., A. Bestetti, R. Marenzi, S. Sala, M. Gisslen, L. Hagberg, and R. W. Price. 2005. Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection. J. Neuroimmunol. 168:154-163. - PubMed
Publication types
MeSH terms
Grants and funding
- T32 AI007001/AI/NIAID NIH HHS/United States
- R01 MH067751/MH/NIMH NIH HHS/United States
- R01 NS037660/NS/NINDS NIH HHS/United States
- P30 CA016086/CA/NCI NIH HHS/United States
- K23-MH074466/MH/NIMH NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- R01-MH81772/MH/NIMH NIH HHS/United States
- UL1RR024131/RR/NCRR NIH HHS/United States
- P30-CA16086/CA/NCI NIH HHS/United States
- K23 MH074466/MH/NIMH NIH HHS/United States
- R01-NS37660/NS/NINDS NIH HHS/United States
- P30 AI050410/AI/NIAID NIH HHS/United States
- T32-AI07001/AI/NIAID NIH HHS/United States
- P30-AI50410/AI/NIAID NIH HHS/United States
- R01-MH67751/MH/NIMH NIH HHS/United States
- R01 MH081772/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
